))
#36 - Stella K. Vnook, CEO at Likarda
Manage episode 407936688 series 3478706
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda.
What you'll get out of this episode:
- Stella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO.
- Likarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy.
- The company aims to enhance cell therapies, especially in liver cells and hormone therapy, and simplify cell transport logistics.
- Likarda's future goals include launching off-the-shelf products for osteoarthritis and advancing partnerships in cell therapy and regenerative medicine.
- Funding strategies and future plans involve a Series A funding round, non-dilutive funding, and efficient use of resources to scale up and innovate.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/vnook/
Company LinkedIn: https://www.linkedin.com/company/likarda-llc/
Website: https://likarda.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
36 episodes
Share
